About Professor Brian Tomlinson

Professor Brian Tomlinson is an internal medicine specialist, with a special interest in lipid disorders, hypertension, and personalised medicine.

Professor Tomlinson received his medical degree from the University of London in 1973. He was Chair Professorof Medicine and Therapeutics in the Department of Medicine and Therapeutics at The Chinese University of Hong Kong, where he spent 25 years in academic appointments. He was also Honorary Consultant Physician at The Prince of Wales Hospital in Hong Kong, Clinical Toxicologist in the Poison Treatment Centre there, as well as the Clinical Director of the Clinical Pharmacology Studies Unit, which performs clinical trials at all stages of drug development including Phase 1. Then, he joined Asia Medial Specialists in 2015.

Professor Tomlinson has a major interest in the genetic determinants of the response to medical treatments and personalised medicine, and also the genetic causes of lipid disorders and other cardiovascular diseases. He was involved with the development of international guidelines for the management of patients with familial hypercholesterolaemia, which were published in several international journals in 2014. He is the author or co-author of over 500 papers in international journals, articles and book chapters and over 500 abstracts from conference presentations.

He is currently Professor in the Faculty of Medicine, Macau University of Science & Technology, Clinical Professor (Honorary) in the Department of Medicine and Therapeutics and Adjunct Professor in The Phase 1 Clinical Research Centre at The Chinese University of Hong Kong. Besides, he is currently Chair of the Asia-Pacific Federation of the International Atherosclerosis Society (IAS) and immediate Past-President of the Asian-Pacific Society of Atherosclerosis & Vascular Diseases.